Cosmos Pharmaceutical Corp banner

Cosmos Pharmaceutical Corp
TSE:3349

Watchlist Manager
Cosmos Pharmaceutical Corp Logo
Cosmos Pharmaceutical Corp
TSE:3349
Watchlist
Price: 6 938 JPY 0.89% Market Closed
Market Cap: ¥555B

Balance Sheet

Balance Sheet Decomposition
Cosmos Pharmaceutical Corp

Balance Sheet
Cosmos Pharmaceutical Corp

Rotate your device to view
Balance Sheet
Currency: JPY
May-2003 May-2004 May-2005 May-2006 May-2007 May-2008 May-2009 May-2010 May-2011 May-2012 May-2013 May-2014 May-2015 May-2016 May-2017 May-2018 May-2019 May-2020 May-2021 May-2022 May-2023 May-2024 May-2025
Assets
Cash & Cash Equivalents
2 373
2 942
6 908
9 178
6 830
10 045
14 201
16 081
18 524
19 101
15 911
21 302
18 635
27 282
27 728
21 668
19 022
52 122
55 108
37 362
45 928
52 301
57 038
Cash Equivalents
2 373
2 942
6 908
9 178
6 830
10 045
14 201
16 081
18 524
19 101
15 911
21 302
18 635
27 282
27 728
21 668
19 022
52 122
55 108
37 362
45 928
52 301
57 038
Total Receivables
521
451
1 012
1 568
1 664
2 128
1 098
1 139
1 430
1 792
2 090
2 346
2 739
2 986
3 387
4 627
5 653
5 879
6 619
8 577
10 221
12 199
12 240
Accounts Receivables
38
39
55
51
57
37
33
31
19
24
22
17
25
28
22
91
398
108
100
198
452
637
761
Other Receivables
483
412
957
1 517
1 607
2 091
1 065
1 108
1 411
1 768
2 068
2 329
2 714
2 958
3 365
4 536
5 255
5 771
6 519
8 379
9 769
11 562
11 479
Inventory
4 379
5 503
8 113
11 687
13 384
14 753
16 433
19 299
19 650
24 199
27 532
31 261
34 863
38 227
40 038
48 749
53 289
53 560
60 549
66 363
77 479
86 173
92 323
Other Current Assets
271
460
570
854
972
1 388
1 369
1 421
1 631
1 803
1 890
2 188
2 185
2 410
2 596
2 281
2 421
2 589
2 849
3 169
3 457
3 660
4 021
Total Current Assets
7 544
9 356
16 605
23 287
22 850
28 314
33 101
37 940
41 235
46 895
47 423
57 097
58 422
70 905
73 749
77 325
80 385
114 150
125 125
115 471
137 085
154 333
165 622
PP&E Net
3 073
4 384
6 533
8 167
13 007
14 581
18 993
21 572
27 236
36 820
51 942
69 147
93 772
114 463
134 450
153 976
172 816
185 374
195 131
225 286
259 464
295 798
331 125
PP&E Gross
3 073
4 384
6 533
8 167
13 007
14 581
18 993
21 572
27 236
36 820
51 942
69 147
93 772
114 463
134 450
153 976
172 816
185 374
195 131
225 286
259 464
295 798
331 125
Accumulated Depreciation
585
843
1 198
1 820
2 633
3 643
4 929
6 606
8 942
11 712
15 280
19 170
25 539
33 726
43 215
53 347
63 335
73 865
84 359
96 695
109 906
126 322
144 359
Intangible Assets
12
13
14
36
49
77
429
482
640
785
802
679
489
332
215
295
287
268
326
433
547
497
446
Long-Term Investments
6
12
11
12
16
16
12
13
13
14
22
22
31
8
4
5
4
5
5
4
4
4
4
Other Long-Term Assets
2 557
3 779
4 951
6 557
8 461
11 035
12 350
13 572
14 852
14 955
15 355
15 755
16 204
16 887
17 273
19 008
20 069
20 486
20 731
21 858
23 867
25 914
27 558
Total Assets
13 192
N/A
17 544
+33%
28 114
+60%
38 059
+35%
44 383
+17%
54 023
+22%
64 885
+20%
73 579
+13%
83 976
+14%
99 469
+18%
115 544
+16%
142 700
+24%
168 918
+18%
202 595
+20%
225 691
+11%
250 609
+11%
273 561
+9%
320 283
+17%
341 318
+7%
363 052
+6%
420 967
+16%
476 546
+13%
524 755
+10%
Liabilities
Accounts Payable
7 203
7 858
12 488
15 810
17 187
23 164
28 890
31 636
37 570
46 081
54 142
66 844
70 773
82 472
91 735
105 062
110 796
136 532
133 041
139 224
161 852
179 549
177 125
Accrued Liabilities
565
812
810
1 105
1 459
1 694
1 802
1 967
2 016
1 902
2 642
2 979
3 971
3 870
5 415
5 088
5 832
8 147
7 504
6 456
8 516
10 083
13 403
Short-Term Debt
768
1 157
2 054
1 849
2 412
2 732
2 549
2 825
2 246
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
0
0
253
371
511
2 437
1 715
2 247
5 395
6 569
6 270
5 029
3 177
3 092
3 095
3 056
4 485
6 512
7 938
Other Current Liabilities
1 049
1 148
1 528
2 483
2 267
2 715
3 414
4 947
5 508
7 803
7 940
9 292
9 485
10 546
10 712
11 257
13 365
14 179
15 897
13 327
17 200
17 085
22 214
Total Current Liabilities
9 584
10 974
16 880
21 247
23 325
30 305
36 908
41 746
47 851
58 223
66 439
81 362
89 624
103 457
114 132
126 436
133 170
161 950
159 537
162 063
192 053
213 229
220 680
Long-Term Debt
2 016
4 023
4 621
2 772
4 837
5 674
7 252
6 657
4 360
2 803
1 951
4 390
11 734
20 099
15 504
12 172
10 698
9 029
7 349
6 357
13 716
27 551
42 019
Other Liabilities
374
400
471
531
611
694
734
770
2 073
2 063
2 204
2 549
2 505
2 860
3 002
3 113
3 404
3 629
3 854
4 125
4 126
4 324
4 593
Total Liabilities
11 975
N/A
15 396
+29%
21 973
+43%
24 550
+12%
28 773
+17%
36 673
+27%
44 894
+22%
49 173
+10%
54 284
+10%
63 089
+16%
70 594
+12%
88 301
+25%
103 863
+18%
126 416
+22%
132 638
+5%
141 721
+7%
147 272
+4%
174 608
+19%
170 740
-2%
172 545
+1%
209 895
+22%
245 104
+17%
267 292
+9%
Equity
Common Stock
242
242
1 389
4 178
4 178
4 178
4 178
4 178
4 178
4 178
4 178
4 178
4 178
4 178
4 178
4 178
4 178
4 178
4 178
4 178
4 178
4 178
4 178
Retained Earnings
798
1 726
2 931
4 720
6 819
8 793
11 437
15 852
21 134
27 822
36 387
45 899
56 548
67 745
84 575
100 426
117 829
137 185
162 065
181 954
202 485
222 284
248 309
Additional Paid In Capital
178
178
1 821
4 610
4 610
4 610
4 610
4 610
4 610
4 610
4 610
4 610
4 610
4 610
4 610
4 610
4 610
4 610
4 610
4 610
4 610
5 101
5 101
Unrealized Security Profit/Loss
0
1
1
1
3
3
1
2
2
3
8
8
15
0
1
1
1
1
1
1
1
1
1
Treasury Stock
0
0
0
0
0
234
234
234
235
235
235
236
236
0
238
238
238
238
238
241
242
225
227
Other Equity
0
0
0
0
0
0
0
0
0
2
2
60
60
119
73
89
91
61
38
5
40
103
101
Total Equity
1 218
N/A
2 148
+76%
6 141
+186%
13 509
+120%
15 610
+16%
17 350
+11%
19 992
+15%
24 408
+22%
29 689
+22%
36 380
+23%
44 950
+24%
54 399
+21%
65 055
+20%
76 179
+17%
93 053
+22%
108 888
+17%
126 289
+16%
145 675
+15%
170 578
+17%
190 507
+12%
211 072
+11%
231 442
+10%
257 463
+11%
Total Liabilities & Equity
13 192
N/A
17 544
+33%
28 114
+60%
38 059
+35%
44 383
+17%
54 023
+22%
64 886
+20%
73 581
+13%
83 973
+14%
99 469
+18%
115 544
+16%
142 700
+24%
168 918
+18%
202 595
+20%
225 691
+11%
250 609
+11%
273 561
+9%
320 283
+17%
341 318
+7%
363 052
+6%
420 967
+16%
476 546
+13%
524 755
+10%
Shares Outstanding
Common Shares Outstanding
18
18
18
20
20
20
20
20
20
20
20
20
40
40
40
40
40
40
40
79
79
79
79
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett